Simple Science

Cutting edge science explained simply

# Health Sciences# Infectious Diseases (except HIV/AIDS)

Tuberculosis in Older Adults: An Emerging Health Crisis

Understanding TB's impact on the aging population is crucial for better health outcomes.

― 5 min read


TB Threatens AgingTB Threatens AgingPopulationcrucial for global health.Addressing TB risks in older adults is
Table of Contents

Tuberculosis (TB) is a serious bacterial infection that affects many people worldwide. It is estimated that about a quarter of the global population carries the bacteria, but many do not show any symptoms. In 2020, almost 10 million people fell ill with TB, and 1.5 million lost their lives to the disease. Active TB disease is often more common in Older Adults, particularly those over 65 years old. As the number of older people in the world grows, understanding how they are affected by TB becomes increasingly important.

The Growing Challenge

The elderly population is expected to increase significantly in the coming years. In 2019, 1 in every 11 people was aged 65 or older. By 2050, this number is projected to change to 1 in 6. Certain regions, including parts of Asia and the Western Pacific, are already seeing high rates of TB cases among older individuals. For example, in Taiwan, it is expected that nearly 80% of new TB cases will occur in older adults by 2035.

Older people are particularly at risk for TB due to several factors. Their immune systems are often weaker, they may have other Health Conditions, and they might live in settings where TB spreads more easily, such as nursing homes. Research indicates that both TB and overall mortality rates are highest among older adults. This poses a significant challenge to global health goals aimed at reducing TB cases and deaths.

Lack of Research

Despite the risk faced by older adults regarding TB, there has not been enough research focused on this age group. Most studies have been conducted in Asian populations, with few examining Hispanic individuals. Investigating the risk factors that contribute to TB in older Hispanics is crucial, especially because issues like poverty and health conditions linked to TB have become more prevalent in recent years.

For instance, in the United States, the TB case rate among Hispanic individuals is significantly higher than that of non-Hispanic whites. Recognizing the impact of aging on efforts to eliminate TB is vital for improving care and preventing more cases.

Study Population and Methods

A detailed study was conducted to gather information on TB in older adults in Tamaulipas, Mexico. Data from 2006 to 2013 was analyzed, focusing on adults aged 18 to 99 who had received a new TB diagnosis. The dataset included over 12,000 patients, but those with previous TB episodes or incomplete data were excluded, leaving a total of 8,381 patients for analysis.

The research aimed to assess differences between older adults and younger adults regarding various factors, including age, sex, education level, Vaccination history, and other health issues. The study also examined whether certain characteristics were linked to poor Treatment Outcomes.

Characteristics of TB Patients

The analysis revealed interesting details about the patient population. The average age of the patients was 43 years, with a majority being male. Many had low education levels, and a significant number were vaccinated against TB at birth. However, a small percentage reported issues like excessive alcohol use or intravenous drug use, and a notable portion had low body weight.

When looking specifically at older adults, it was found that they had lower education levels and vaccination rates compared to younger adults. The presence of other health conditions like chronic obstructive pulmonary disease (COPD) and diabetes was also more prominent in older patients.

TB-Related Characteristics

The majority of TB patients had pulmonary TB, and a large proportion tested positive for bacteria through sputum smear tests. Most diagnoses were based on smear results rather than cultures. Older adults showed lower rates of extrapulmonary TB compared to younger groups but had more close contacts, suggesting potential higher exposure.

Regarding drug resistance, testing was less common in older patients. However, it was noted that the prevalence of drug-resistant TB decreased with age, indicating that older adults might have less severe forms of the disease.

Treatment Outcomes

The study also examined treatment outcomes for the patients. Overall, 14.9% faced adverse outcomes such as treatment failure, abandoning treatment, or death. The rates were notably higher among older adults, with many older patients less likely to abandon their treatment compared to younger individuals. However, they were more likely to die while receiving treatment.

For older adults, factors like male sex, previous positive bacterial tests, and having drug-resistant TB significantly increased the likelihood of treatment failure. Interestingly, higher education levels were protective against treatment failure, suggesting that access to education could influence health outcomes.

Trends Over Time

Examining trends from 2006 to 2013, the study found that the characteristics of older patients remained fairly consistent. However, there were signs of improvement in education levels, vaccination rates, and the incidence of some TB-related characteristics over time.

The findings highlighted the complexity of factors affecting TB in older adults. While some risk factors like diabetes appeared to have protective effects, others like COPD presented additional challenges.

Conclusion

The extensive data analysis provides valuable insights into the challenges and risks associated with TB in older adults. The aging population facing this disease must be prioritized in public health strategies, especially since they tend to experience worse outcomes.

It is essential to recognize that the elderly face a different set of risks compared to younger populations. A greater focus on their unique needs, including better access to education and health resources, can help improve their treatment outcomes and reduce mortality rates.

Efforts to raise awareness and promote tailored interventions for older adults with TB could significantly impact their health and well-being. Addressing these issues will be critical for meeting global health goals related to TB elimination, ultimately benefiting not just older populations, but society as a whole.

Original Source

Title: Tuberculosis presentation and outcomes in elderly Hispanics from Tamaulipas, Mexico

Abstract: Old people are at high risk of developing and dying from pulmonary infections like tuberculosis (TB), but they are few studies and particularly in Hispanics. To address these gaps, we sought to identify host factors associated with TB and adverse treatment outcomes in old Hispanics by conducting a secondary analysis of TB surveillance data from Tamaulipas, Mexico (2006-2013; n=8,381). Multivariable logistic regressions were assessed for the elderly (ELD, [≥]65 years) when compared to young (YA, 18 to 39 years) and middle-aged adults (MAA, 40 to 64 years). We found that the ELD had features associated with a less complicated TB (e.g. less extra-pulmonary TB, abandoning of treatment or having drug resistant TB), and yet, were more likely to die during TB treatment (adj-OR 3.9, 95% 2.5, 5.25). Among the elderly, excess alcohol use and low BMI increased their odds of death, while diabetes and BCG vaccination were protective. These data suggest that old people share some, but not all the risk factors for adverse TB treatment outcomes, when compared with younger adults. Furthermore, even though old age in itself is an important predictor of death during TB, the elderly are not prioritized by the World Health Organization for latent TB infection screening and treatment during contact investigations. We propose the inclusion of the elderly as a high-risk group in TB management guidelines.

Authors: Blanca I. Restrepo, B. A. Medrano, M. Lee, G. Gemeinhardt, J. E. Rodriguez-Herrera, M. Garcia-Viveros

Last Update: 2023-03-20 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2023.03.14.23287283

Source PDF: https://www.medrxiv.org/content/10.1101/2023.03.14.23287283.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles